Related Experiment Video
Updated: Feb 15, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses
Published on: June 25, 2011
Designing and building oncolytic viruses
Justin Maroun1, Miguel Muñoz-Alía1, Arun Ammayappan1
1Department of Molecular Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Abstract:
Oncolytic viruses (OVs) are engineered and/or evolved to propagate selectively in cancerous tissues. They have a dual mechanism of action; direct killing of infected cancer cells cross-primes anticancer immunity to boost the killing of uninfected cancer cells. The goal of the field is to develop OVs that are easily manufactured, efficiently delivered to disseminated sites of cancer growth, undergo rapid intratumoral spread, selectively kill tumor cells, cause no collateral damage and pose no risk of transmission in the population. Here we discuss the many virus engineering strategies that are being pursued to optimize delivery, intratumoral spread and safety of OVs derived from different virus families. With continued progress, OVs have the potential to transform the paradigm of cancer care.
Insights
Oncolytic viruses (OVs) are engineered to target and destroy cancer cells, while also stimulating the immune system to fight cancer. Ongoing research focuses on optimizing OV delivery, spread, and safety for improved cancer treatment.
Area of Science:
- Oncolytic virotherapy
- Cancer immunotherapy
- Viral engineering
Background:
- Oncolytic viruses (OVs) selectively replicate in cancer cells, leading to direct tumor cell lysis.
- OVs possess a dual mechanism: direct cancer cell killing and induction of anti-cancer immunity.
- Current challenges include efficient delivery, intratumoral spread, and safety of OVs.
Purpose of the Study:
- To review virus engineering strategies for optimizing oncolytic viruses (OVs).
- To enhance OV delivery, intratumoral spread, and safety profiles.
- To discuss the potential of OVs in transforming cancer care paradigms.
Main Methods:
- Discussion of various virus engineering strategies applied to different OV families.
- Focus on optimizing parameters for enhanced therapeutic efficacy and safety.
- Review of approaches to improve viral delivery and tumor cell targeting.
Main Results:
- Multiple engineering strategies are being pursued to improve OV performance.
- Progress in optimizing OV delivery, spread, and safety is highlighted.
- Engineered OVs show promise for enhanced cancer treatment.
Conclusions:
- Oncolytic viruses offer a promising therapeutic strategy for cancer treatment.
- Continued advancements in virus engineering are crucial for realizing OV potential.
- OVs have the potential to significantly impact future cancer care.
Related Concept Videos
Design Example: Sustainability in Concrete Building
There are multiple approaches to achieve sustainability in a commercial concrete building. For instance, construct a concrete parking area under the building, utilizing pervious concrete paver blocks in open areas to facilitate rainwater collection through an underground...
What are Viruses?
Group Design
Movement Joints in Buildings
The simplest type of movement joints, working joints, are...
Types of Building Stone
Igneous rocks are formed from the solidification of magma or lava. An example is granite, known for its durability and resistance to weathering, making it ideal for parts of...
Factorial Design

